​

Becton, Dickinson and Company (BDX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Becton, Dickinson and Company Revenue Highlights

Latest Revenue (Y)

$20.18B

Latest Revenue (Q)

$5.51B

Main Segment (Y)

Medical

Main Geography (Y)

UNITED STATES

Becton, Dickinson and Company Revenue by Period

Becton, Dickinson and Company Revenue by Year

DateRevenueChange
2024-09-30$20.18B4.16%
2023-09-30$19.37B2.66%
2022-09-30$18.87B-6.81%
2021-09-30$20.25B18.29%
2020-09-30$17.12B-1.00%
2019-09-30$17.29B8.18%
2018-09-30$15.98B32.17%
2017-09-30$12.09B-3.12%
2016-09-30$12.48B21.41%
2015-09-30$10.28B21.74%
2014-09-30$8.45B4.87%
2013-09-30$8.05B4.48%
2012-09-30$7.71B-1.54%
2011-09-30$7.83B6.19%
2010-09-30$7.37B2.95%
2009-09-30$7.16B0.07%
2008-09-30$7.16B12.52%
2007-09-30$6.36B9.00%
2006-09-30$5.83B7.76%
2005-09-30$5.41B9.73%
2004-09-30$4.93B8.98%
2003-09-30$4.53B12.27%
2002-09-30$4.03B7.43%
2001-09-30$3.75B3.76%
2000-09-30$3.62B5.85%
1999-09-30$3.42B9.67%
1998-09-30$3.12B10.90%
1997-09-30$2.81B1.47%
1996-09-30$2.77B2.11%
1995-09-30$2.71B5.98%
1994-09-30$2.56B3.82%
1993-09-30$2.47B-

Becton, Dickinson and Company generated $20.18B in revenue during NA 2024, up 4.16% compared to the previous quarter, and up 116.70% compared to the same period a year ago.

Becton, Dickinson and Company Revenue by Quarter

DateRevenueChange
2025-06-30$5.51B4.50%
2025-03-31$5.27B2.01%
2024-12-31$5.17B-4.95%
2024-09-30$5.44B8.96%
2024-06-30$4.99B-1.09%
2024-03-31$5.04B7.20%
2023-12-31$4.71B-7.49%
2023-09-30$5.09B4.28%
2023-06-30$4.88B1.18%
2023-03-31$4.82B5.12%
2022-12-31$4.59B-3.68%
2022-09-30$4.76B2.59%
2022-06-30$4.64B-7.38%
2022-03-31$5.01B6.21%
2021-12-31$4.72B-8.12%
2021-09-30$5.13B5.01%
2021-06-30$4.89B-0.35%
2021-03-31$4.91B-7.68%
2020-12-31$5.32B11.10%
2020-09-30$4.78B24.10%
2020-06-30$3.85B-9.36%
2020-03-31$4.25B0.66%
2019-12-31$4.22B-7.83%
2019-09-30$4.58B5.38%
2019-06-30$4.35B3.69%
2019-03-31$4.20B0.84%
2018-12-31$4.16B-5.50%
2018-09-30$4.40B2.90%
2018-06-30$4.28B1.33%
2018-03-31$4.22B37.08%
2017-12-31$3.08B-2.72%
2017-09-30$3.17B4.32%
2017-06-30$3.04B2.22%
2017-03-31$2.97B1.61%
2016-12-31$2.92B-9.56%
2016-09-30$3.23B1.03%
2016-06-30$3.20B4.27%
2016-03-31$3.07B2.71%
2015-12-31$2.99B-2.42%
2015-09-30$3.06B-1.92%
2015-06-30$3.12B52.12%
2015-03-31$2.05B-
2014-12-31$2.05B-6.86%
2014-09-30$2.20B2.09%
2014-06-30$2.16B4.10%
2014-03-31$2.07B2.83%
2013-12-31$2.02B-4.08%
2013-09-30$2.10B2.34%
2013-06-30$2.05B2.61%
2013-03-31$2.00B5.27%
2012-12-31$1.90B-3.40%
2012-09-30$1.97B-0.67%
2012-06-30$1.98B-0.52%
2012-03-31$1.99B5.47%
2011-12-31$1.89B-7.96%
2011-09-30$2.05B1.82%
2011-06-30$2.01B4.79%
2011-03-31$1.92B4.34%
2010-12-31$1.84B6.32%
2010-09-30$1.73B-7.76%
2010-06-30$1.88B1.81%
2010-03-31$1.84B-3.75%
2009-12-31$1.92B1.00%
2009-09-30$1.90B4.26%
2009-06-30$1.82B4.56%
2009-03-31$1.74B0.42%
2008-12-31$1.73B-5.56%
2008-09-30$1.84B-1.71%
2008-06-30$1.87B6.91%
2008-03-31$1.75B-

Becton, Dickinson and Company generated $5.51B in revenue during Q3 2025, up 4.50% compared to the previous quarter, and up 109.20% compared to the same period a year ago.

Becton, Dickinson and Company Revenue Breakdown

Becton, Dickinson and Company Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceSep 24Sep 23Sep 22Sep 21Sep 20
Life Sciences$5.19B$2.30B---
Interventional$4.98B----
Medical$10.07B$2.00B---
Products and/or Services-$2.30B$2.50B$2.10B$1.90B
Consumables-$2.00B$1.90B$2.50B$2.60B

Becton, Dickinson and Company's latest annual revenue breakdown by segment (product or service), as of Sep 24: Medical (49.76%), Life Sciences (25.64%), and Interventional (24.60%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Medical$2.93B$2.76B$2.62B$5.82B$2.10B$1.11B$1.05B$581.00M$552.00M$486.00M----------
Life Sciences$1.25B$1.25B$1.30B$299.00M$2.30B$1.30B$1.29B$930.00M$1.18B$377.00M----------
Interventional$1.33B$1.26B$1.26B$4.04B$489.00M$454.00M$318.00M$306.00M$293.00M-----------
Products and/or Services------$2.20B-$2.50B$2.50B$2.50B$2.20B$2.20B$2.10B$1.90B$1.90B$1.90B---
Consumables------$2.20B-$2.10B$2.20B$1.90B$2.10B$2.40B$2.40B$2.80B$2.70B$2.60B---

Becton, Dickinson and Company's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Medical (53.13%), Interventional (24.11%), and Life Sciences (22.76%).

Becton, Dickinson and Company Revenue Breakdown by Country

Annual Revenue by Country

CountrySep 24Sep 23Sep 22Sep 21Sep 20
UNITED STATES$11.66B$11.11B$10.72B$10.97B$9.72B
Asia$2.91B$2.91B$3.05B$3.27B$2.57B
Europe$4.40B$4.24B$3.48B--
Others Country$1.21B$1.10B$1.06B$1.25B$1.35B
EMEA-$4.24B$4.04B$4.75B-

Becton, Dickinson and Company's latest annual revenue breakdown by geography, as of Sep 24: UNITED STATES (57.80%), Europe (21.82%), Asia (14.40%), and Others Country (5.98%).

Quarterly Revenue by Country

CountryJun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
UNITED STATES$3.18B$3.11B$3.08B$3.12B$2.89B$2.91B$2.75B$2.88B$2.77B$2.73B$2.73B$2.71B$2.64B$2.81B$2.85B$2.80B$2.57B$2.46B$3.13B$2.75B
Non-US$2.33B$2.16B$2.09B$2.10B$2.14B$1.96B$2.21B$2.11B$2.09B$1.86B$2.05B$2.00B$2.20B$2.14B$2.33B$2.32B$2.45B$2.19B$2.03B-

Becton, Dickinson and Company's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (57.74%), and Non-US (42.26%).

Becton, Dickinson and Company Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CORCencora$293.96B$80.66B
BDXBecton, Dickinson and$20.18B$5.51B
REGNRegeneron Pharmaceuticals$14.20B$3.68B
ALCAlcon$10.09B$2.46B
ZTSZoetis$9.26B$2.46B
AAgilent$6.83B$1.74B
EWEdwards Lifesciences$5.44B$1.53B
RMDResMed$5.15B$1.22B
IDXXIDEXX Laboratories$3.90B$1.11B
VEEVVeeva Systems$2.75B$789.08M
ARGXargenx SE$1.23B$401.00M

BDX Revenue FAQ

What is Becton, Dickinson and Company’s yearly revenue?

Becton, Dickinson and Company's yearly revenue for 2024 was $20.18B, representing an increase of 4.16% compared to 2023. The company's yearly revenue for 2023 was $19.37B, representing an increase of 2.66% compared to 2022. BDX's yearly revenue for 2022 was $18.87B, representing a decrease of -6.81% compared to 2021.

What is Becton, Dickinson and Company’s quarterly revenue?

Becton, Dickinson and Company's quarterly revenue for Q3 2025 was $5.51B, a 4.50% increase from the previous quarter (Q2 2025), and a 10.40% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $5.27B, a 2.01% increase from the previous quarter (Q1 2025), and a 4.50% increase year-over-year (Q2 2024). BDX's quarterly revenue for Q1 2025 was $5.17B, a -4.95% decrease from the previous quarter (Q4 2024), and a 9.82% increase year-over-year (Q1 2024).

What is Becton, Dickinson and Company’s revenue growth rate?

Becton, Dickinson and Company's revenue growth rate for the last 3 years (2022-2024) was 6.93%, and for the last 5 years (2020-2024) was 17.88%.

What are Becton, Dickinson and Company’s revenue streams?

Becton, Dickinson and Company's revenue streams in p 24 are Life Sciences, Interventional, and Medical. Life Sciences generated $5.19B in revenue, accounting 25.64% of the company's total revenue, up 125.70% year-over-year. Interventional generated $4.98B in revenue, accounting 24.60% of the company's total revenue Medical generated $10.07B in revenue, accounting 49.76% of the company's total revenue, up 403.70% year-over-year.

What is Becton, Dickinson and Company’s main source of revenue?

For the fiscal year ending Sep 24, the largest source of revenue of Becton, Dickinson and Company was Medical. This segment made a revenue of $10.07B, representing 49.76% of the company's total revenue.